Genmab — November 2020
-
Winkel føler sig mere og mere sikker på at de har et "best in class" molecule der kan tage kampen op med Regeneron og Roche.
-
God morgen.
-
Torsdagens aviser med Vestas, Genmab og Danske Bankhttps://www.proinvestor.com/investornyt/669315/torsdagens-aviser-med-vestas-genmab-og-danske-bank
-
-
-
Nordea hæver Genmab målkurs til 2074 fra 2071
-
Velkommen til den nye AMBU chat https://www.proinvestor.com/index.php?p=group&groupid=126
-
-
Genmab A/S (GMAB) CEO Jan van de Winkel on Q3 2020 Results - Earnings Call Transcript https://seekingalpha.com/article/4385141-genmab-s-gmab-ceo-jan-van-de-winkel-on-q3-2020-results-earnings-call-transcript?utm_campaign=twitter_automated&utm_content=article&utm_medium=social&utm_source=twitter_automated
-
As you will understand by SITC, you will definitely see a very nice data set from the dose escalation with the PD-L1x4-1BB bispecific antibody. And yes, I think the fact that it has been selected for presentation and highlighting at the press conference probably already tells enough at this point.
-
Aktier/tendens: Genmab, Matas og Vestas i fokus i ventet grøn åbninghttps://www.proinvestor.com/investornyt/669325/aktier-tendens-genmab-matas-og-vestas-i-fokus-i-ventet-gron-abning
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind